Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Josep

Riera-Monroig

,

MD

Dermatologist
Hospital Clínic de Barcelona
Barcelona
,
Spain
2024 Fellow
IPC Jr. Councilor
Dr. Josep Riera-Monroig is a consultant dermatologist leading the Psoriasis Unit at the Department of Dermatology, Hospital Clínic de Barcelona, Spain. He is also a lecturer at the Faculty of Medicine, University of Barcelona. His work in psoriasis focuses on novel therapeutic approaches and identifying exposome-related triggers, such as microbiome alterations and the characteristics of emotional stressors linked to disease flares. His clinical expertise also includes rare genetic disorders, such as generalized pustular psoriasis and disorders of epidermal differentiation. Dr. Riera-Monroig has served as principal investigator in multiple clinical trials and research studies. He has participated in educational programs such as the International Alliance for Global Health Dermatology (GLODERM) and serves as Secretary of the Catalan Society of Dermatology and Venereology. He is also an active member of the Spanish Psoriasis Group of the Academia Española de Dermatología y Venereología (AEDV). For his IPC Fellowship, Dr. Riera-Monroig undertook research training with IPC Councilor Dr. Wilson Liao at the University of California, San Francisco.
Last Updated:
01/01/2025

Areas of Interest

Environmental & emotional triggers, Palmoplantar involvement, Palmoplantar pustulosis, Treatment optimization, Biomarkers to predict psoriatic arthritis

Languages Spoken

English, Spanish

Involvement with Other Organization(s)

Dr. Riera-Monroig collaborates with the psoriasis patient association, Acción Psoriasis, and organizations for rare conditions such as DEBRA and ASIC. He also serves on his hospital’s drug approval committee.

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026